CA2650922C — Pre-mixed, ready-to-use pharmaceutical compositions
Assigned to EKR Therapeutics Inc · Expires 2015-09-29 · 11y expired
What this patent protects
Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: from about 0.1 to about 0.4 mg/mL nicardipine or a pharmaceutically acceptable salt thereof; a tonicity agent; and a buffer; wherein the composition requires no dilution bef…
USPTO Abstract
Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: from about 0.1 to about 0.4 mg/mL nicardipine or a pharmaceutically acceptable salt thereof; a tonicity agent; and a buffer; wherein the composition requires no dilution before administration and has a pH from about 3.6 to about 4.7.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.